Gene expression profiling of HER2-positive breast cancer samples collected at baseline and at surgery from patients who did not achieve pathological complete response after trastuzumab-based neoadjuvant biochemotherapy.

ABSTRACT: Transcriptomic analysis of a cohort of patients with HER2-positive breast cancer who did not achieve a pathological complete response after neoadjuvant treatment with trastuzumab plus chemotherapy. Matched samples were collected before the initiation of therapy (diagnostic biopsy) and at surgery (surgical sample).

ORGANISM(S): Homo sapiens

PROVIDER: GSE245132 | GEO | 2025/01/29

REPOSITORIES: GEO